Nuveen Dividend Growth ETF (NDVG) 시세

Could, of course as far as the EU goes (and most likely ROW) only a BP will be able to garner sales worth mentioning. 4 million is not worth even mentioning after all this time. But that also brings to mind the catch wrt a potential takeover. Amarin will never be able (in at least some reasonable

MSFT Microsoft Seasonality (Last 19 Years)
By: TrendSpider | March 15, 2025

• Microsoft sits in the middle of the Mag 7 pack YTD, trading down ~7% and trailing only AAPL and META. But momentum could be shifting. MSFT is entering its strongest four-week stretch of seasonali

style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px"Spam another board bud. Oh wait you do. Someone obviously has an agenda. 

The Ides of March
44 B.C.

Julius Caesar, dictator of Rome, is stabbed to death in the Roman Senate house by 60 conspirators led by Marcus Junius Brutus and Gaius Cassius Longinus on March 15. The day later became infamous as the Ides of March.

Also on This Day in

GDVM: ERATE Contracts Won and more coming, Solid updates here! Hope everyone seen these two press releases from Yesterday.

~~~ VeeMost Technologies Expands Growth Strategy, Provides Update on FINRA Approval & Strategic Direction
March 14, 2025 10:00
https://www.globene

Spam another board bud. Oh wait you do. Someone obviously has an agenda. 

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175931116

It’s the nobel prize Micro RNA scientific sabotage at all levels including the FDA

So many expanding tentacles that it’s impossible for me to imagine how we’d do everything without a major player providing upfront funding.
100% agree and I will say I heard some very positive signals in this direction

Are these RNA editing indications even necessary with regular RNAI-SIRNA drug pipeline of 450 drugs seems like most of these editing drugs like gene editing are all flops companies not sure about RNA Editing when companies like ALNY and Novartis have the goods to make good old fashion Sirna drugs

QQQ Seasonality (Last 18 Years)
By: TrendSpider | March 15, 2025

• The QQQ has dropped 11% from all-time highs, slipping just below the 200-day EMA for the first time since March 2023. While the technicals look weak, seasonality paints a different picture. The coming weeks

So... How's that name change request with FINRA coming along Johnney???

It's been close to six months now...

.


Watch your wallet


Buyer Beware
Pump and Dump
http://images.investorshub.advfn.com/images/u

There's always "potential" doesn't mean squat. So now we go from Seamus barely being able to run one company to him pulling strings for three?? This is not when hemp first hit the stock market and everyone could make money even the scams did. Nope this is 2025 the AImarket has been cornered already

TTX- The cancer cure short sabotage

X. The closer we get the more some worry and the crazier some of the posts get.

The closer we get to under a stinking dollar per share, it is proven how incredibly crazy, all of your years of pretend Xpertise were. Just sayin you had no clue what was going on with LWLG

lol
I said that just last week . Same were pumping approval a year ago . As I said a week ago , now they will say , that they expected this time line all along .
He is the worst pumper . 

Here are a FEW examples of what we deal with
The Smokehouse Creek Fire, which burned across northern Texas and western Oklahoma in late February and early March, is considered the largest fire in Oklahoma's history, consuming an estimated 1,059,570 acres.
Here's a more detailed breakd

https://youtu.be/pM76LtznNrc?si=aZiD8qMfSR60ttDc

Thank you JTFM. This is encouraging. Isn't part of this growth simply due to moving from a 5 ml vial to a 1 ml syringe? Regardless, what matters most is the pricing and I expect there is a premium paid for the self dosing alternative.

QQQ Weekly Analysis
By: TrendSpider | March 15, 2025

• The QQQ ETF also extended its decline last week, closing at $479.66 (-2.46%). Similar to SPY, the GoNoGo Trend indicator flashed a neutral candle along with a weekly close below the lower Bollinger Band, a rare occurre

Timing and luck are two of the most important things in making investment decisions. It appears that both are working in Elite's favor now. With the threat of tariffs affecting major foreign generic drug makers, merger and acquisition activity has increased making this little gem a prime candidate e

It’s the bankrupt MULN of the pharmaceutical Mi-RNA cure to cancer sabotage

https://www.sec.gov/ix?doc=/Archives/edgar/data/0000897078/000149315225010288/form8-k.htm

Morrison quits the scam known as Apollo Biwellness aka Resonate Blends aks Emergent Health.....criminal what these clowns did

Don’t even bother, Ex. The disciples will just keep repeating the same old nonsense regardless. They ride coat tails.